ATE286878T1 - 3,4-dihydro-1h-naphthalin-derivate als hoch selektive cyclooxygenase-2-inhibitoren - Google Patents

3,4-dihydro-1h-naphthalin-derivate als hoch selektive cyclooxygenase-2-inhibitoren

Info

Publication number
ATE286878T1
ATE286878T1 AT02022313T AT02022313T ATE286878T1 AT E286878 T1 ATE286878 T1 AT E286878T1 AT 02022313 T AT02022313 T AT 02022313T AT 02022313 T AT02022313 T AT 02022313T AT E286878 T1 ATE286878 T1 AT E286878T1
Authority
AT
Austria
Prior art keywords
dihydro
highly selective
inhibitors
selective cyclooxygenase
naphthaline derivatives
Prior art date
Application number
AT02022313T
Other languages
English (en)
Inventor
Il Hwan Cho
Jee Woong Lim
Ji Young Noh
Jong Hoon Kim
Gwanyang-Dong
Sang Wook Park
Woncheon-Dong
Hyung Chul Ryu
Je Hak Kim
Hyung Ok Chun
So Young Wang
Sung Hak Lee
Original Assignee
Cheil Jedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cheil Jedang Corp filed Critical Cheil Jedang Corp
Application granted granted Critical
Publication of ATE286878T1 publication Critical patent/ATE286878T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/24Sulfones; Sulfoxides having sulfone or sulfoxide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/32Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02022313T 2001-10-10 2002-10-08 3,4-dihydro-1h-naphthalin-derivate als hoch selektive cyclooxygenase-2-inhibitoren ATE286878T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010062488A KR100824233B1 (ko) 2001-10-10 2001-10-10 사이클로옥시게나제-2의 저해제로서 선택성이 뛰어난3,4-디하이드로-1h-나프탈렌 유도체

Publications (1)

Publication Number Publication Date
ATE286878T1 true ATE286878T1 (de) 2005-01-15

Family

ID=19715011

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02022313T ATE286878T1 (de) 2001-10-10 2002-10-08 3,4-dihydro-1h-naphthalin-derivate als hoch selektive cyclooxygenase-2-inhibitoren

Country Status (8)

Country Link
US (2) US6686493B2 (de)
EP (1) EP1306368B1 (de)
JP (1) JP3977222B2 (de)
KR (1) KR100824233B1 (de)
CN (1) CN1239478C (de)
AT (1) ATE286878T1 (de)
DE (1) DE60202575T2 (de)
WO (1) WO2003031418A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS7839A (is) * 2002-11-22 2004-05-23 Merck Frosst Canada Ltd. 4-oxó-1-(3-setið fenýl-1,4-díhýdró-1,8-naftýridín-3-karboxamíð fosfódíesterasa-4 hindrar
CN110023291B (zh) * 2016-11-30 2023-07-18 百时美施贵宝公司 三环rho激酶抑制剂
CN107011266B (zh) * 2017-05-02 2023-04-14 中国人民解放军第二军医大学 苯并吲唑类衍生物的前药及其制备方法、应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474995A (en) 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
US6077869A (en) * 1998-10-29 2000-06-20 Ortho-Mcneil Pharmaceutical, Inc. Aryl phenylhydrazides as selective COX-2 inhibitors for treatment of inflammation
EP1099695A1 (de) 1999-11-09 2001-05-16 Laboratoire Theramex S.A. 5-Aryl-1H-1,2,4-triazolverbindungen als Cyclooxygenase-2 Inhibitoren und diese enthaltende pharmazeutische Zusammensetzungen

Also Published As

Publication number Publication date
EP1306368B1 (de) 2005-01-12
DE60202575D1 (de) 2005-02-17
DE60202575T2 (de) 2006-01-12
EP1306368A3 (de) 2003-07-02
US6686493B2 (en) 2004-02-03
EP1306368A2 (de) 2003-05-02
CN1239478C (zh) 2006-02-01
US20030109715A1 (en) 2003-06-12
JP2003176264A (ja) 2003-06-24
US6768019B2 (en) 2004-07-27
KR20030030379A (ko) 2003-04-18
KR100824233B1 (ko) 2008-04-24
WO2003031418A1 (en) 2003-04-17
JP3977222B2 (ja) 2007-09-19
CN1418870A (zh) 2003-05-21
US20030187302A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
ATE465146T1 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
NO20062644L (no) DPP-IV inhibitorer
NO20052884L (no) Substituerte indolpyridinforbindelser som anti-infeksjonsmidler.
FR15C0086I2 (fr) Derives d'hydroxamate en tant qu'inhibiteurs de desacetylase
DK1569899T3 (da) Substituerede 3-alkyl- og 3-arylalkyl-1H-indol-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
DK1487444T3 (da) Anvendelse af pyridylamider som angiogeneseinhibitorer
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
PL361404A1 (en) Synergistic combinations comprising a renin inhibitor for cardiovascular diseases
DE602004008098D1 (de) Substituierte 2h-ä1,2,4ütriazoloä4,3-aüpyrazine als gsk-3-inhibitoren
NO331013B1 (no) Nye forbindelser som er anti-inflammasjons, immunomodulerende og anti-proliferative midler, anvendelse av forbindelsene samt farmasoytisk preparat
HN2002000028A (es) Pirimidinas inhibidoras de metaloproteinasas
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ATE278661T1 (de) Anthranilsäurederivate
NO944371D0 (no) Kjemisk forbindelse med blodplateaggregeringsinhiberende virkning
DK1043310T3 (da) Biphenylamidinderivater
ATE308540T1 (de) Antithrombosemittel
ATE360612T1 (de) In 4-stellung substituierte piperidinderivate
ATE348800T1 (de) 4'-methansulfonylbiphenylderivate als hochselektive cyclooxygenase-2-inhibitoren
DE60333578D1 (de) Lamellarinanaloga mit antitumorwirkung
ATE286878T1 (de) 3,4-dihydro-1h-naphthalin-derivate als hoch selektive cyclooxygenase-2-inhibitoren
ATE366727T1 (de) Diaryl-1,2,4-triazolderivate als hochselektive cyclooxygenase-2-inhibitoren
BR0002514A (pt) Derivados de 4-arilpiperidina para o tratamento de prurido
DE602004009306D1 (de) 3,4-dihydro-1h-chinolin-2-onderivate als norepinephrin-wiederaufnahme-hemmern
ATE455100T1 (de) Bipyridinylderivate als hochselektive cyclooxygenase-2-inhibitoren
UY26973A1 (es) Derivados puente de piperazina

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties